autologous dinitrophenyl-modified ovarian cancer vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011609
A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.
| Identifier | MLC-T-ONC-011609 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous DNP-modified ovarian cancer vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011609",
"term": "autologous dinitrophenyl-modified ovarian cancer vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine consisting of autologous ovarian cancer cell peptide antigens conjugated to the hapten 2,4-dinitrophenol (DNP) with potential immunostimulating and antineoplastic activities. Administration of autologous dinitrophenyl-modified ovarian cancer vaccine may induce a cytotoxic T-lymphocyte (CTL) response against ovarian cancer cells. DNP conjugation may enhance the immunogenicity of weakly immunogenic antigens.",
"synonyms": [
"autologous DNP-modified ovarian cancer vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-dinitrophenyl-modified-ovarian-cancer-vaccine/"
}
Record 2,943 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.